Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Gene associated with pair-bonding in animals has similar effects in human males

Gene associated with pair-bonding in animals has similar effects in human males

September 04, 2008

Variation in the gene for one of the receptors for the hormone vasopressin appears to be associated with how human males bond with their partners, according to an international team of researchers.

The researchers found that the "334" allele of a common AVPR1A variation, the human version of avpr1a studied in voles, seemed to have negative effects on men's relationship with their spouses.




"Our findings are particularly interesting because they show that men who are in a relatively stable relationship of five years of more who have one or two copies of allele 334 appear to be less bonded to their partners than men with other forms of this gene," says Jenae Neiderhiser, professor of psychology, Penn State. "We also found that the female partners of men with one or two copies of allele 334 reported less affection, consensus and cohesion in the marriage, but interestingly, did not report lower levels of marital satisfaction than women whose male partners had no copies of allele 334."

In voles, a mouse-like animal, the comparable gene has been studied extensively and has long been linked to vole bonding behaviors. This is the first study to suggest that the wealth of information on vole pair-bonding may also apply to humans and may help to inform research on human disorders related to impaired social interactions and communication, such as autism.

A series of studies on vole populations, begun at the NIMH Intramural Research Program in the mid 1980s, showed that, in male rodents, variations in a section of the gene avpr1a affect social bonding behaviors, such as choosing a mate and parenting. The animal studies suggested a possible connection between a seemingly useless piece of DNA and bonding behavior. Recently, some research on AVPR1A in humans suggest a possible link with autism and certain social behaviors, such as altruism, but no direct link to human pair-bonding had previously been known.

"A study by Erica Spotts, National Institute on Aging, using this sample was one of the first to show genetic influences on marital relationships, but did not reveal which genes were involved," says Neiderhiser. "The work on pair bonding in voles was very exciting because it suggested to us a specific gene to examine."

Neiderhiser, Paul Lichtenstein, the Karolinska Institute in Sweden, and colleagues interviewed 2,186 adults taking part in the Twin and Offspring Study in Sweden (TOSS). The TOSS study collected detailed information from pairs of twins and their partners or spouses about their marital relationships, personality and mental health, as well as genetic data.

They report in this week's on-line issue of the Proceedings of the National Academy of Sciences that, in men, having allele 334 was inversely linked to measures of the strength of a person's bond to their mate. They also report that men who carried two copies of allele 334 were more than twice as likely to report serious marital or relationship problems, such as facing threat of divorce, as men who had did not carry it. These men also were almost twice as likely to be unmarried as men with no copies, despite having a long-term relationship with their mate.

Women married to men with one or two copies of allele 334 reported lower scores on measures of marital quality than women married to men not carrying this allele.

Allele 334 is also associated with increased activity in the amygdala, a brain region involved in regulating emotions.

"In this new paper, Hasse Walum did an excellent job of linking this work to the work with voles by constructing the partner bonding measure that was then examined for associations with polymorphism in the gene AVPR1A," says Neiderhiser.

The researchers caution that their findings do not suggest this genetic variation can be used to predict an individual's pair-bonding behavior. However, their study complements findings from similar animal research and suggests that the well-defined relationship between genes, the brain and pair-bonding behavior in voles may also be relevant for humans.

Penn State



Related Vasopressin Current Events and Vasopressin News Articles Vasopressin Current Events and Vasopressin News RSS Vasopressin Current Events and Vasopressin News RSS
Potential new targets for antidepressant medications
The news about antidepressant medications over the past several years has been mixed. The bad news from large multicenter studies such as STAR*D is that current antidepressant medications are effective, but not as effective as one might hope. Thus, there is a significant need for new treatment mechanisms for depression.

EVEREST data on use of tolvaptan published in JAMA and featured at ACC
Once-daily dosing with Otsuka's investigational oral medication tolvaptan, a vasopressin receptor antagonist, was associated with improvements in signs and symptoms of acutely decompensated heart failure (ADHF) in hospitalized patients receiving conventional care, without an adverse effect on their long-term survival versus placebo.

Psychologist Says Neurochemical Processes Explain Romantic Attraction
The Beatles' George Harrison wondered in his famous love song about the 'something' that 'attracts me like no other lover.'

Sodium, prostaglandin may be keys to successful treatment for some bedwetters
Children with a form of bedwetting that does not respond to a common medication have more sodium and urea in their nighttime urine, possibly because of an imbalance of prostaglandin, a hormone-like substance, a new study has found.

Animal models show that anabolic steroids flip the adolescent brain's switch for aggression
Anabolic steroids not only make teens more aggressive, but may keep them that way into young adulthood.

Trust-building hormone short-circuits fear in humans
A brain chemical recently found to boost trust appears to work by reducing activity and weakening connections in fear-processing circuitry, a brain imaging study at the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) has discovered.

Larry Young on animals and autism clues, environmental impact on hormone brain function
As animal models go, the vole isn't near the top of the list. In fact, it wasn't even on the list until relatively recently. Not to be confused with the mole, a much smaller and scientifically less-interesting rodent, voles are about the size of hamsters, but more squat.

Hormonal signaling in the brain: radical shift in understanding information processing
Two University of Edinburgh professors from the Centre for Integrative Physiology describe how "our understanding of how the brain processes information is undergoing a radical shift as we begin to recognize the implications of hormonal signaling systems within the brain itself," explained Gareth Leng.

New Emergency Drug for Cardiac Arrest
Vasopressin as an agent for cardio-pulmonary resuscitation Diseases of the cardiovascular system continue to be the most frequent causes of death in the Western world. For over 100 years, Adrenaline has been the standard drug of choice in the treatment of sudden cardiac arrest. A team of researchers headed by Karl H. Lindner and Volker Wenzel from the University Department of Anaesthesiology and Critical Care Medicine, University of Innsbruck, has, with the support of the Austrian Science Fund (FWF) and after years of successful investigations, proved that Vasopressin is at least as successful as Adrenaline as an emergency drug used in cardio-pulmonary resuscitation. In fact, in 2000 the f

Delayed neurological development contributes to night-time bedwetting in some children
Night-time bedwetting in some children is likely to be caused by delayed neurological development, finds research in the Archives of Disease in Childhood. This can be predicted by a drawing test, shows the research. Thirty four children aged between 7 years and 13 were studied. They all wet the bed at least four times a week. The children were patients at a specialist clinic and had been treated with a synthetic version of the hormone vasopressin. Produced by the pituitary gland, this hormone reduces urine production. The children took a specially devised validated neuro-psychological test (Rey-Osterrieth test), which has been in used since 1941. In the form of a linear figure, it tests plan
More Vasopressin Current Events and Vasopressin News Articles


Roles of Vasopressin and Oxytocin in Memory Processing, Volume 50 (Advances in Pharmacology)
by Barbara McEwen

The Roles of Vasopressin and Oxytocin in Memory Processing reviews research progress in a subfield of Behavioral Pharmacology concerned with vasopressin's (VP's) and oxytocin (OT's) roles in memory processing (MP). As hormones, VP is well-known for its pressor and antidiuretic action, and OT for its contribution to parturition and nursing. As neurotransmitters, they participate in a wide variety...



Advances in Brain Vasopressin (Progress in Brain Research)

Advances in Brain Vasopressin elucidates the functions of the regulatory peptide vasopressin in the nervous system, and reviews the current status of this field at different levels.It deals with the cell biology and anatomy of the neurons that produce vasopressin in the brain, and provides an overview on the receptors of vasopressin and the signal transduction pathways that they activate,...



Advances in Vasopressin and Oxytocin - From Genes to Behaviour to Disease, Volume 170 (Progress in Brain Research) (Progress in Brain Research)

Vasopressin and oxytocin are the key hormones of the hypothalamo-neurohypophysial system, and are well-known to be critically involved in antidiuresis, labor, and milk ejection. This book highlights the latest research on vasopressin and oxytocin, covering multiple biological aspects. The capacity of both hormones to regulate various aspects of social behaviours including pair-bonding,...



Vasopressin and Oxytocin: Molecular, Cellular, and Clinical Advances (Advances in Experimental Medicine and Biology)

This monograph provides a comprehensive overview of recent advances in the field of vasopressin and oxytocin. In the summer of 1997, scientists from over 20 countries congregated in Montreal for the 1997 World Congress of Neurohypophysial Hormones, a conference that united the fields of vasopressin, neurohypophysis, and oxytocin in a single joint meeting that gave rise to the present book....

Vasopressin blocker shows diuretic activity: new drug class for heart failure.(Rx): An article from: Internal Medicine News
by Mitchel L. Zoler

This digital document is an article from Internal Medicine News, published by International Medical News Group on January 15, 2004. The length of the article is 617 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web...



Depression with above-normal plasma vasopressin: Validation by [An article from: Psychiatry Research
by J.G. Goekoop, R.P.F. de Winter, R. de Rijk, Zwinde

This digital document is a journal article from Psychiatry Research, published by Elsevier in 2006. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.Abstract: An anxious-retarded subtype of depression has been derived from the DSM-IV category of melancholia. It is defined by combined high...

Vasopressin;

Agent eases edema in heart failure: vasopressin-receptor blocker.(Clinical Rounds)(tolvaptan): An article from: Family Practice News
by Mitchel L. Zoler

This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2004. The length of the article is 680 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Replacement therapy: arginine vasopressin (AVP), growth hormone (GH), cortisol, thyroxine, testosterone and estrogen. (includes test on replacement therapy): ... from: Journal of Neuroscience Nursing
by Dawn H. Mitchell, Betty Owens

This digital document is an article from Journal of Neuroscience Nursing, published by American Association of Neuroscience Nurses on June 1, 1996. The length of the article is 8553 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any...

Neurobiology of Vasopressin (Current Topics in Neuroendocrinology)
by D. Ganten

© 2008 BrightSurf.com